logo
Plus   Neg
Share
Email

Sanofi Q3 Profit Down - Quick Facts

Sanofi (SNYNF,SNY) reported that its third-quarter net income attributable to equity holders of the company declined to 1.766 billion euros from 2.274 billion euros last year. IFRS Earnings per share were 1.41 euros down from 1.82 euros in the previous year.

Earnings per share excluding the exchanged/held-for-exchange Animal Health business was 1.49 euros, down 18.6% reflecting the capital gain on the European generics divestment in the third-quarter of 2018.

Business net income increased 4.3% to 2.399 billion euros and 0.2% at constant exchange rates or CER. Business earnings per share increased 4.3% to 1.92 euros on a reported basis and was stable at CER.

Quarterly sales were 9.499 billion euros, up 1.1% on a reported basis. Exchange rate movements had a positive effect of 2.2 percentage points mainly driven by the strength of the U.S. dollar which was partially offset by the negative impact from the Argentine Peso. At CER, sales decreased 1.1%.

Sanofi Genzyme sales increased 19.5% driven by continued strong uptake of Dupixent.

Sanofi expects 2019 business earnings per share to grow about 5% at CER barring unforeseen major adverse events.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT